Kevin Caldwell
29 posts

Kevin Caldwell
@KevinCaldweII
CEO and Co-Founder @ Ossium Health


2,850 days. Almost 8 years. That's how long it took to save a life. In August of 2016 my @firstround partner, @btrenchard, led @OssiumHealth's Seed round. And in May of 2024, a 68 year-old woman in Michigan became the first patient to receive a bone marrow transplant from a deceased donor. When she was not able to find a bone marrow match from a living donor, she enrolled in Ossium's PRESERVE I clinical trial -- and matched with bone marrow stored in at Ossium's biobank (the only bone marrow biobank in the world). Until now, every time an organ donor died, their bone marrow was discarded. Thrown away. Regardless of whether there was a cancer patient who was a genetic match and desperately needed that bone marrow. Ossium figured out how to collect, process and cryopreserve bone marrow from deceased organ donors. Their network of 27 organ procurement organizations recovers bone marrow from organ donors and transports it to Ossium's facility where the company processes and manufactures the doses for the patients -- and cryopreserves it in their biobank. Before Ossium it typically took months to find a living bone marrow donor who is: a) a genetic match, b) healthy enough, and c) willing to donate. And those are months that a blood cancer patient often doesn't have. Today there is a woman in Michigan who is alive -- and on a great recovery trajectory from her blood cancer, because Ossium had a bone marrow unit that could match her and save her life. Congrats to Kevin Caldwell and the entire Ossium team. We can't wait to see the impact you have over the next 2,850 days. More info here: foxnews.com/health/leukemi…

















